Siemens and Zeta drive forward the digital transformation of pharmaceutical processes worldwide
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 170 years. Active around the world, the company focuses on intelligent infrastructure for buildings and distributed energy systems and on automation and digitalization in the process and manufacturing industries. Siemens brings together the digital and physical worlds to benefit customers and society. Through Mobility, a leading supplier of intelligent mobility solutions for rail and road transport, Siemens is helping to shape the world market for passenger and freight services. Via its majority stake in the publicly listed company Siemens Healthineers, Siemens is also a world-leading supplier of medical technology and digital health services. In addition, Siemens holds a minority stake in Siemens Energy, a global leader in the transmission and generation of electrical power that has been listed on the stock exchange since September 28, 2020.
In fiscal 2019, which ended on September 30, 2019, the Siemens Group generated revenue of €58.5 billion and net income of €5.6 billion. As of September 30, 2019, the company had around 295,000 employees worldwide on the basis of continuing operations. Further information is available on the Internet at www.siemens.com.
The Zeta Group specializes in the planning, design, development, production, automation, digitization and (preventive) maintenance of customer-specific processes for aseptic applications. It employs around 800 people. Highly complex, customized plants produce biopharmaceutical active ingredients such as anticancer agents, insulin, vaccines and IV therapies. Zeta supports its customers along the entire development and production process with mature and sophisticated solutions from laboratory to industrial production of active ingredients.